Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2020

Aug 10, 2020

31802_dirs_2020-08-10_8756ff25-b4d1-4fbc-8947-f848a32a557a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-08-06

Reporting Person: Wirick Angela L (Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 47505 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-qualified Stock Option (right to buy) $16.95 2024-07-28 Common Stock (5000) Direct

Footnotes

F1: Includes 24,044 shares of unvested restricted stock awarded under the AtriCure, Inc. 2014 Equity Incentive Plan. One third of the shares vest annually upon the respective one, two and three year anniversaries of the date of grant. Restricted stock awarded prior to 2018 vests at a rate of 25% on the first anniversary date of the grant and ratably each month thereafter over the following three years.

F2: These options were granted on July 28, 2014 and vest at a rate of 25% on the first anniversary date of the grant and ratably each month thereafter over the following three years.